About
Peptide for various disorders
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyOther European
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
233
By Phase
PHASE2: 1PHASE1/PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04395456Lead Sponsor
A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)
PHASE2Unknown
144 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2022
NCT03694444Lead Sponsor
A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis
PHASE1/PHASE2Completed
39 participants
Started: Jul 22, 2019 · Completed: Oct 30, 2020
NCT03316521Lead Sponsor
First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers
PHASE1Completed
50 participants
Started: Apr 24, 2017 · Completed: Nov 30, 2017
Locations (1)
Headquarters
Glyfada, Greece
Map
Loading map...